Related Experiment Videos

Association of Variability of Monthly Continuous Glucose Monitoring-Derived Metrics With Diabetic Kidney Disease in

Byeongjae Kang1,2, Rosa Oh3, Taeyoung Kim1

  • 1Medical AI Research Center, Research Institute for Future Medicine, Samsung Medical Center, Seoul, Republic of Korea.

Insights

The standard deviation of monthly time in range (TIR) and time in tight range (TITR) are key indicators for diabetic kidney disease (DKD) in type 1 diabetes (T1D). Machine learning models effectively identify DKD risk using these continuous glucose monitoring metrics.

Area of Science:

  • Endocrinology
  • Nephrology
  • Data Science

Background:

  • Hemoglobin A1c (HbA1c) is standard for glycaemic control but misses glycaemic variability.
  • Continuous glucose monitoring (CGM) offers longitudinal data for improved diabetes management.
  • Diabetic kidney disease (DKD) is a major complication in type 1 diabetes (T1D).

Purpose of the Study:

  • Investigate the discriminatory capacity of longitudinal CGM metrics.
  • Identify CGM metric patterns associated with DKD in T1D.
  • Utilize machine learning (ML) for DKD risk prediction.

Main Methods:

  • Analyzed 1-year CGM data from 282 T1D patients.
  • Defined DKD by persistent albuminuria or reduced eGFR.
  • Developed and compared ML models (LightGBM, XGBoost, Random Forest, Logistic Regression).

Main Results:

  • LightGBM model achieved highest performance (AUROC=0.91).
  • Standard deviation (SD) of monthly time in range (TIR) and time in tight range (TITR) were most influential features.
  • SD of monthly TIR and TITR remained elevated even in early DKD.

Conclusions:

  • SD of monthly TIR and TITR strongly associate with DKD in T1D.
  • CGM metrics offer improved DKD discrimination beyond HbA1c.
  • ML integration of longitudinal CGM data enhances DKD assessment.
Abstract

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate01:25

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...